Terns Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -41.75M-50.24M-60.58M-90.28M-89.56M
Depreciation and Depletion 0.40M0.50M0.50M0.30M0.30M
Share-based Compensation 1.69M8.15M10.77M25.54M15.63M
Gains from Sales and Divestitures 0.08M0.07M
Gains from Investment Securities 0.18M0.24M1.59M0.07M1.30M
Non-cash Items 26.70M1.94M2.54M
Cash from Operations -29.81M-41.83M-49.11M-67.39M-70.02M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.55M0.59M0.58M
Amortization of Deferred Charges 0.04M0.88M0.08M-5.21M-2.09M
Depreciation & Amortization (CF) 0.39M0.51M0.48M0.29M0.32M
Change in Working Capital
Change in Account Payables -1.15M1.73M-0.72M1.15M-0.37M
Change in Accured Expenses 4.78M-3.37M1.42M2.73M4.24M
Investing Activities
Capital Expenditures 0.58M0.34M0.28M0.05M0.04M
Change in Acquisitions & Divestments 7.99M46.94M117.73M237.85M157.57M
Cash from Investing Activities 6.69M-119.70M-22.27M-37.99M-12.41M
Financing Activities
Other financing activities 0.86M2.72M0.40M0.34M0.39M
Debt Issuance and Repayment
Long-Term Debt Issuances 16.88M0.24M0.41M
Short-Term Debt repayments 12.88M
Change in Capital Stock
Shares Issued 0.12M136.36M81.11M0.41M1.45M
Preferred Shares Issued 69.38M
Misc.
Cash from Financing Activities 85.52M134.39M167.09M41.95M164.00M
Exchange Rate Effect 0.08M-0.03M-0.18M0.12M-0.06M
Change in Cash 62.48M-27.16M95.54M-63.31M81.51M
Beginning Cash Balance 12.38M74.85M47.70M63.31M-81.51M
Free Cash Flow -30.39M-42.17M-49.38M-67.44M-70.06M
Net Cash Flow 62.40M-27.13M95.71M-63.43M81.57M